Back to Search Start Over

Interleukin-6 signaling drives fibrosis in unresolved inflammation.

Authors :
Fielding CA
Jones GW
McLoughlin RM
McLeod L
Hammond VJ
Uceda J
Williams AS
Lambie M
Foster TL
Liao CT
Rice CM
Greenhill CJ
Colmont CS
Hams E
Coles B
Kift-Morgan A
Newton Z
Craig KJ
Williams JD
Williams GT
Davies SJ
Humphreys IR
O'Donnell VB
Taylor PR
Jenkins BJ
Topley N
Jones SA
Source :
Immunity [Immunity] 2014 Jan 16; Vol. 40 (1), pp. 40-50. Date of Electronic Publication: 2014 Jan 09.
Publication Year :
2014

Abstract

Fibrosis in response to tissue damage or persistent inflammation is a pathological hallmark of many chronic degenerative diseases. By using a model of acute peritoneal inflammation, we have examined how repeated inflammatory activation promotes fibrotic tissue injury. In this context, fibrosis was strictly dependent on interleukin-6 (IL-6). Repeat inflammation induced IL-6-mediated T helper 1 (Th1) cell effector commitment and the emergence of STAT1 (signal transducer and activator of transcription-1) activity within the peritoneal membrane. Fibrosis was not observed in mice lacking interferon-γ (IFN-γ), STAT1, or RAG-1. Here, IFN-γ and STAT1 signaling disrupted the turnover of extracellular matrix by metalloproteases. Whereas IL-6-deficient mice resisted fibrosis, transfer of polarized Th1 cells or inhibition of MMP activity reversed this outcome. Thus, IL-6 causes compromised tissue repair by shifting acute inflammation into a more chronic profibrotic state through induction of Th1 cell responses as a consequence of recurrent inflammation.<br /> (Copyright © 2014 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1097-4180
Volume :
40
Issue :
1
Database :
MEDLINE
Journal :
Immunity
Publication Type :
Academic Journal
Accession number :
24412616
Full Text :
https://doi.org/10.1016/j.immuni.2013.10.022